Related Experiment Videos
A sensitive sandwich-enzyme immunoassay for human endothelin
N Suzuki1, H Matsumoto, C Kitada
1Tsukuba Research Laboratories, Takeda Chemical Industries, Ltd., Ibaraki, Japan.
Journal of Immunological Methods
|March 31, 1989
Summary
A new sensitive enzyme immunoassay (EIA) for human endothelin(1-21) was developed. This assay can detect low levels of endothelin, with preliminary results showing basal levels in male plasma.
Area of Science:
- Biochemistry
- Immunology
- Endocrinology
Background:
- Endothelin (1-21) is a potent vasoconstrictor with significant physiological roles.
- Accurate measurement of endothelin levels is crucial for understanding cardiovascular and renal diseases.
- Existing assays may lack the sensitivity or specificity required for precise quantification.
Purpose of the Study:
- To establish a highly sensitive enzyme immunoassay (EIA) for human endothelin (1-21).
- To characterize the performance of the newly developed EIA.
- To determine the basal levels of immunoreactive endothelin in human plasma.
Main Methods:
- Development of a sandwich enzyme immunoassay using two distinct anti-endothelin antibodies.
- Immobilization of a monoclonal anti-endothelin antibody (AwETN40).
- Use of a horseradish peroxidase (HRP)-labeled Fab' fragment of rabbit antibodies against the endothelin C-terminal heptapeptide as the detector.
Main Results:
- The developed EIA demonstrates high sensitivity, detecting as little as 0.2 pg/well (80 amol/well) of endothelin.
- The assay utilizes a specific antibody combination for reliable detection.
- Preliminary analysis of male plasma samples (n=24) revealed basal immunoreactive endothelin levels of 1.59 +/- 0.32 pg/ml after Seppak C-18 extraction.
Conclusions:
- A sensitive and specific EIA for human endothelin (1-21) has been successfully established.
- The assay is suitable for quantifying endothelin in biological samples.
- The findings provide a baseline for endothelin levels in healthy males, aiding further research.